HAE - Haemonetics Corporation
NEXT EARNINGS:
May 14, 2026
EPS Est: $1.29
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$86.60
DETAILS
HIGH:
$94.00
LOW:
$80.00
MEDIAN:
$88.00
CONSENSUS:
$86.60
UPSIDE:
40.40%
Market Cap:
2.89B
Volume:
698,594
Avg Volume:
851,771
52 Week Range:
47.32-87.32
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.27
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
3,657
IPO Date:
1991-05-10
EPS (TTM):
3.31
P/E Ratio:
18.97
Revenue (TTM):
1.36B
Total Assets:
2.45B
Total Debt:
1.22B
Cash & Equiv:
306.76M
Rev Growth (5Y):
5.9%
EPS Growth (5Y):
20.7%
FCF Growth (5Y):
23.4%
ROCE:
13.2%
Debt/Equity:
1.49
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $1.31 | $1.27 | +3.1% | $339.0M | $337.0M | +0.6% |
| 2025-11-06 | $1.27 | $1.12 | +13.4% | $327.3M | $329.8M | -0.7% |
| 2025-08-07 | $1.10 | $1.01 | +8.9% | $321.4M | $320.0M | +0.4% |
| 2025-05-08 | $1.24 | $1.22 | +1.6% | $330.6M | $312.5M | +5.8% |
| 2025-02-06 | $1.19 | $1.18 | +0.8% | $348.5M | $354.5M | -1.7% |
| 2024-11-07 | $1.12 | $1.09 | +2.8% | $345.5M | $342.6M | +0.8% |
| 2024-08-08 | $1.02 | $1.03 | -1.0% | $336.2M | $335.4M | +0.2% |
| 2024-05-09 | $0.90 | $0.88 | +2.3% | $343.3M | $329.1M | +4.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.36B | 1.31B | 1.17B | 993.20M | 870.46M | 988.48M | 967.58M | 903.92M | 886.12M | 908.83M | 910.37M | 938.51M |
| Net Income | 167.68M | 117.56M | 115.40M | 43.38M | 79.47M | 76.53M | 55.02M | 45.57M | (26.27M) | (55.62M) | 16.90M | 35.15M |
| EPS | 3.31 | 2.32 | 2.27 | 0.85 | 1.57 | 1.51 | 1.07 | 0.86 | -0.51 | -1.09 | 0.33 | 0.68 |
| Total Assets | 2.45B | 2.20B | 1.93B | 1.86B | 1.82B | 1.27B | 1.27B | 1.24B | 1.24B | 1.32B | 1.48B | 1.52B |
| Total Debt | 1.22B | 807.79M | 765.89M | 780.78M | 778.28M | 441.81M | 350.12M | 253.68M | 314.65M | 408.00M | 427.89M | 437.69M |
| Cash & Equivalents | 306.76M | 178.80M | 284.47M | 259.50M | 192.31M | 137.31M | 169.35M | 180.17M | 139.56M | 115.12M | 160.66M | 192.47M |
| Operating Cash Flow | 181.72M | 181.75M | 273.06M | 172.26M | 108.81M | 158.22M | 159.28M | 220.35M | 159.74M | 121.86M | 127.18M | 139.52M |
| Free Cash Flow | 142.45M | 115.45M | 162.87M | 75.75M | 71.77M | 109.46M | 40.32M | 145.55M | 83.60M | 19.46M | 4.96M | 65.88M |
| FCF per Share | 2.83 | 2.28 | 3.21 | 1.48 | 1.42 | 2.16 | 0.78 | 2.76 | 1.62 | 0.38 | 0.10 | 1.28 |
| Book Value | 820.84M | 959.96M | 818.00M | 749.42M | 731.67M | 587.11M | 667.87M | 752.43M | 739.61M | 719.98M | 826.12M | 839.61M |
| Cash & ST Investments | 306.76M | 178.80M | 284.47M | 259.50M | 192.31M | 137.31M | 169.35M | 180.17M | 139.56M | 115.12M | 160.66M | 192.47M |
| ROC Equity | 0.20 | 0.12 | 0.14 | 0.06 | 0.11 | 0.13 | 0.08 | 0.06 | -0.04 | -0.08 | 0.02 | 0.04 |